UnknownPhase 4NCT02477852

The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis

Studying Tuberculosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Chest Hospital
Principal Investigator
shao fa xu, doctor
Beijing Chest Hospital
Intervention
Isoniazid(drug)
Enrollment
400 enrolled
Eligibility
15-75 years · All sexes
Timeline
20152017

Study locations (1)

Collaborators

Beijing Municipal Science & Technology Commission

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02477852 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis

← Back to all trials